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Abstract
Background: The spectrum of indications for the use of membranes and scaffolds in the field of oral and
maxillofacial surgery includes, amongst others, guided bone regeneration (GBR). Currently available membrane
systems face certain disadvantages such as difficult clinical handling, inconsistent degradation, undirected cell
growth and a lack of stability that often complicate their application. Therefore, new membranes which can
overcome these issues are of great interest in this field.
Methods: In this pilot study, we investigated polycaprolactone (PCL) scaffolds intended to enhance oral wound
healing by means of melt electrospinning writing (MEW), which allowed for three-dimensional (3D) printing of micron
scale fibers and very exact fiber placement. A singular set of box-shaped scaffolds of different sizes consisting of
medical-grade PCL was examined and the scaffolds’ morphology was evaluated via scanning electron microscopy
(SEM). Each prototype sample with box sizes of 225 μm, 300 μm, 375 μm, 450 μm and 500 μm was assessed for
cytotoxicity and cell growth by seeding each scaffold with human osteoblast-like cell line MG63.
Results: All scaffolds demonstrated good cytocompatibility according to cell viability, protein concentration,
and cell number. SEM analysis revealed an exact fiber placement of the MEW scaffolds and the growth of
viable MG63 cells on them. For the examined box-shaped scaffolds with pore sizes between 225 μm and
500 μm, a preferred box size for initial osteoblast attachment could not be found.
Conclusions: These well-defined 3D scaffolds consisting of medical-grade materials optimized for cell attachment and
cell growth hold the key to a promising new approach in GBR in oral and maxillofacial surgery.
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Background
In the field of oral and maxillofacial surgery, membranes
are used for a broad spectrum of indications including
Guided bone regeneration (GBR) applications. In this
context, membranes function as a barrier between
fast-proliferating soft tissues, such as fibrous connective
tissue or epithelium and the rather slow-proliferating
bone [1]. Using scaffold geometries and surfaces that are
tailored to the requirements of bone tissue may promote
bone regeneration in GBR.
In general, membranes that are currently used for
maxillofacial applications, such as GBR, can be broadly
divided into resorbable and non-resorbable categories.
Membranes of the latter category offer good biocompati-
bility and high mechanical stability. Thus they suit very
well as placeholders and barriers in GBR. On the other
hand, non-resorbable membranes require a second
operation for their removal, pose a risk of mucosal
perforations due to their high level of stiffness and
therefor go along with higher morbidity, increased
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costs and increased expenditure of time. By contrast, re-
sorbable membranes currently mostly consist of collagen,
synthetic aliphatic polyesters, or their co-polymers [2–4].
Normally, resorbable membranes that are currently used
show excellent biocompatibility, a reduced risk of wound
dehiscence, and good biodegradability. On the other hand,
especially for in GBR most commonly used collagen
membranes, a rapid loss of mechanical stability is appar-
ent, and their clinical handling is often not ideal due to
their low resilience and lubricity. Furthermore, as these
membranes are either of allogeneic or xenogeneic origin, a
potential risk of transmission of infection as well as poten-
tial legal, ethical or religious limitations have to be consid-
ered [2, 5]. In total, all available membrane systems for
oral applications maintain certain drawbacks. One prom-
ising approach to producing membranes/scaffolds that
compensate for the disadvantages of currently available
membranes is electrospinning [6] - and even more re-
cently, melt electrospinning writing (MEW) [7]. Electro-
spinning is a versatile and easy technique to produce
scaffolds for biomedical applications. In electrospinning,
an electrically charged, viscous polymer jet is ejected from
a spinneret and “drawn” through the air in the direction
of a collector with opposite electrical potential where the
fibers form either chaotic mats or well-defined structures
depending on which electrospinning method is being used
[8]. Regarding the initial state of the polymer, two different
types of electrospinning can be distinguished: solution
electrospinning and MEW. In solution electrospinning,
polymers are dissolved in organic solvents, such as chloro-
form or dimethylformamide, which evaporate when the
polymer jet is ejected towards the collector. Disadvantages
of the solution spinning process include the resulting solv-
ent residues in the fibers as well as the fact that only
uncontrolled fiber deposition is feasible due to elec-
trostatic forces and concomitant increased bending
and deflection of the polymer jet [9, 10]. MEW, in
contrast allows for a very exact placement of fibers made
from medical-grade polymers up to sub-micrometer scale
without the use of any solvents and with no risk of re-
sidual toxic solvents in the finished scaffold [11–15]. This
placement can be achieved because the polymer is
not dissolved, but melted. Process parameters allow
for a controlled fiber placement, which makes the
computer-aided design- and manufacturing (CAD/
CAM) of 3D scaffolds feasible. Cell growth on scaf-
folds can thus be optimized by varying pore sizes and
interconnectivity.
For this study, medical-grade PCL scaffolds with
box-shaped pores with sizes of 225, 300, 375, 450,
and 500 μm were fabricated for a perspective applica-
tion in GBR, seeded with an osteoblast-like cell line,




All scaffolds that were used in this pilot study consisted
of medical-grade PCL purchased from Corbion Inc.
(Gorinchem, Netherlands, PURASORB PC 12). It was
divided into 50mL falcon tubes in an argon atmosphere
and stored at − 80 °C until used.
Fabrication via MEW
For scaffold fabrication, we used a custom-made MEW
device that was designed and built by the Department
for Functional Materials in Medicine and Dentistry
Würzburg University Hospital (Fig. 1) [11]. The machine
parameters were adjusted to produce fibers with diame-
ters of approximately 20 μm. The PCL was heated inside
the device at 73.0 °C ± 1.0 °C in a disposable plastic syr-
inge with a 22G needle attached to it (both from
Nordson EFD Deutschland GmbH, Pforzheim, Germany).
A pneumatic pressure of 1.2 bars was applied to the
melted polymer, and an acceleration voltage of 6 kV was
used between the tip of the needle and the stainless-steel
collector. The distance between both was 4mm, and the
collector moved at a rate of 400mm/min. MEW was per-
formed at an ambient temperature of 21.4 °C ± 0.4 °C and
a humidity level of 38.5 ± 3.5%. The polymer was used
within 5 days.
Scaffold designs
One series of box-structured MEW scaffolds was evalu-
ated for all experiments. MEW was performed by alter-
nating the layer deposition via 0° and 90° layers (15 × 15
mm2) in each direction with turning loops. Five layers
were deposited in each direction (0° and 90°) such that
10 fibers overlapped at intersections. Scaffolds with fiber
diameters of 20 μm and different filament spacings of
225 μm, 300 μm, 375 μm, 450 μm and 500 μm were fabri-
cated in this manner. 100% ethanol was used to separate
the scaffolds from the metal collector.
Scanning electron microscopy (SEM)
All different scaffolds were characterized by SEM im-
aging to evaluate the accuracy of the MEW process.
MEW scaffolds were washed four times with Phos-
phate Buffered Saline (PBS, Invitrogen, Karlsruhe,
Germany). After fixation with 6% glutaraldehyde (Merck,
Darmstadt, Germany), the scaffolds were dehydrated
in rising concentrations of ethanol and finally dried
with hexamethyldisilazane (Thermo Fisher Scientific,
Waltham, USA) and sputter coated with platinum
using a Leica EM ACE600 (Leica Microsystems GmbH,
Wetzlar, Germany).
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Cell culture
Human osteoblast-like cell line MG63 was cultivated in
Dulbecco’s Modified Eagle’s Medium (DMEM, Invitro-
gen, Karlsruhe, Germany), which was supplemented with
10% fetal calf serum (FCS, Invitrogen, Karlsruhe,
Germany) and 1% penicillin and streptomycin (P/S, Invi-
trogen, Karlsruhe, Germany) in a prewarmed (37 °C) and
humidified atmosphere with 5% CO2. The culture
medium was changed every 3 days.
MG63 cells were seeded upon the box-structured scaf-
folds in an initial concentration of 3.0 × 105 cells per
scaffold. In vitro experiments were performed in 12-well
multiwell plates (Thermo Fisher Scientific, Waltham,
USA). Scaffolds were placed into a well and weighed
down by a glass ring and glass beads to keep them from
floating in the cell culture medium (Fig. 2). Positive con-
trols consisted of cells with a glass ring and negative
controls consisted of the cell culture medium and the
cell culture medium with a glass ring and beads.
Measurements for cell-viability, cell counting, and pH
measurements were performed on days 2, 3 and 4 of
cell settlement to assess initial cell attachment. Phal-
loidin staining, FDA/PI staining and the measurement
of protein concentration were performed on day 4 of
the cell culture.
Cytocompatibility testing
Water-soluble tetrazolium (WST-1) assay
Cell viability reflects the amount of metabolically active
cells and was tested with WST-1 assay (Roche Diagnos-
tics, Mannheim, Germany). Prior to WST-1 testing, the
fixation rings were removed, and the scaffolds were
transferred to new 12-well multiwell plates. The scaf-
folds were then incubated with WST-1 reagent di-
luted 1:10 in medium for 30 min at 37 °C. 200 μl of
the medium supernatant were then transferred into a
cavity of a 96-well plate, and optical density was mea-
sured photometrically (Tecan Spektra Rainbow, Tecan,
Crailsheim, Germany) at 440 nm.
Protein concentration assay
A quantitative assessment of the overall protein concen-
tration of cells on scaffolds was performed according to
the Lowry method [16] and the quantification of protein
level was determined using a BSA standard curve. After
washing the scaffolds three times with PBS (Invitrogen,
Karlsruhe, Germany), they were covered with PBS and
20% NaOH (Merck, Darmstadt, Germany), sealed with
MT-film (Tecan, Crailsheim, Germany), incubated at 80
°C for 1 hour, and finally neutralized with 20% HCl
(Merck, Darmstadt, Germany). For the assessment of
Fig. 1 Design of MEW device and schematic of the MEW process of the scaffolds
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the protein concentration, DC Protein-Assay with re-
agent S, A and B was used (BIO-RAD, München,
Germany). Standards and scaffold samples were added
with working reagent (reagent A + S) and reagent B and
stirred carefully. After 15 min, a color change to blue
could be observed, and a photometric measurement at
750 nm was performed.
Cell counting
Prior to the counting process, cells were detached from
the scaffold surface by incubation with 0.05% trypsin
(Thermo Fisher Scientific, Waltham, USA) for 5 min and
then washed and resuspended in DMEM. The cells
that had settled upon the scaffolds were counted with
a Coulter counter (Casy 1, Schärfe Systeme, Reut-
lingen, Germany).
pH-value measurement
pH values were determined prior to viability testing for
the assessment of solubility and degradation activity of
some PCL scaffolds by collecting supernatant from the
cell culture medium and evaluating its pH values with a
pH meter in combination with a pH electrode (SenTix
61, WTW, Weilheim, Germany).
Phalloidin staining
After removing the medium, the scaffolds were washed
with PBS and then fixed with 4% paraformaldehyde
(Histofix, Carl Roth, Karlsruhe, Germany) for 10 min.
After rinsing the scaffolds with PBS, treating them with
0,1% triton x-100 (Sigma-Aldrich, Taufkirchen, Germany),
and performing another PBS rinsing, 1% bovine serum al-
bumin was applied for 30min. Next, phalloidin (Thermo
Fisher Scientific, Waltham, USA) was added, and the
scaffolds were incubated for 1 h in complete darkness.
Afterwards, the scaffolds were examined via fluores-
cence microscopy (BIOREVO BZ-9000, Keyence, Neu-
Isenburg, Germany).
Fluorescindiacetate/Propidiumiodide (FDA/PI) staining
The scaffolds were washed once with PBS and then cov-
ered with a 1:9 mixture of FDA and PI (Sigma-Aldrich,
Taufkirchen, Germany) for 10 s. After rinsing once more




WST-1 testing revealed good cell proliferation of MG63
cells on all PCL scaffolds (Fig. 3). Cell proliferation on
all scaffolds of all box sizes always remained more- or
less distinct behind the control groups consisting of
MG63 cells growing on cell culture plates (polystyrene).
For the 225 μm and 500 μm box-size scaffolds, a pro-
gression of cell viability could be observed over time.
The other sizes revealed inconsistent growth behavior
(Fig. 4). Overall, 225 μm scaffolds displayed the highest
viability, with a general decrease towards the larger
box sizes.
The measurement of the protein concentration of
MG63 cells seeded on differently sized scaffolds yielded
values between 432.5 μg/ml and 858.5 μg/ml. Substantial
differences could generally not be found (Fig. 5). Only
500 μm scaffolds displayed higher protein concentrations
than the 225 μm and 300 μm scaffolds.
Cell counting revealed the presence of viable MG63
cells over the 4 days (Fig. 6). The cell counts varied be-
tween 21.0 × 105 (225 μm, day 3) and 1.3 × 105 (450 μm,
day 2). Most viable MG63 cells were found on scaffolds
of 225 μm and 450 μm box sizes. A uniform trend could
not be found.
An analysis of the pH values of the cell culture super-
natant revealed physiological values (Fig. 7) that consist-
ently lay within the range of 7.85 and 8.03 and complied
with values of the pure cell culture medium.
Morphological characterization
Figure 8 displays an example of a MEW PCL scaffold
with a box size of 250 μm. Exact fiber placement and
box geometry can be seen. SEM micrographs further
Fig. 2 Schematic of cell culture experiments on the scaffolds
Fuchs et al. BMC Oral Health           (2019) 19:28 Page 4 of 11
exhibited growth of viable MG63 cells with flattened
morphology and cell protrusions mostly at the intersec-
tions of polymer fibers of different layers.
Histopathological FDA/PI and phalloidin staining also
revealed good cell attachment (Figs. 9 and 10) for the
different box sizes. Viable cells could be found not only
at intersections but also along straight fibers.
Discussion
The aim of this pilot study was to develop scaffolds for
an application in oral and maxillofacial surgery to
overcome the drawbacks of currently used membrane
systems. To achieve this goal, we used MEW as an
Fig. 3 Cell viability of MG63 cells upon MEW box structured PCL scaffolds of different box sizes. Cell viability was measured via WST-1 after 2, 3,
and 4 days. a) Box size 225 μm, b) box size 300 μm, c) box size 375 μm, d) box size 400 μm, e) box size 500Μm. medium: pure DMEM, scaffold:
MEW PCL scaffolds burdened with glass ring/beads, scaff+MG63 + ring: MG63 cells seeded on PCL scaffolds burdened with glass ring/beads,
MG63 + ring: MG63 cells seeded on polystyrene wells of multiwell plates in presence of glass ring/beads
Fig. 4 Cell viability displayed in Fig. 3 in direct comparison, itemized by box size
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emerging technology in tissue engineering that enables
the fabrication of scaffolds in almost unlimited designs
without the use of toxic components. The long-term ob-
jective is to generate multilayered scaffolds for oral re-
generation that simultaneously fulfill all requirements
for a sufficient regeneration of oral tissues, such as mu-
cosa and bone. These multilayered membranes should
fulfill all requirements of GBR such as complete cell
occlusivity, which is not yet realized with the scaffolds
used in our study, as they have relatively wide fiber spac-
ings up to 500 μm. Nevertheless, as a first step towards
this goal, in this pilot study, we examined the possibility
of fabricating MEW scaffolds for bone regeneration and
of influencing the growth behavior of osteoblast-like
cells through a variation of scaffold designs.
Thus far, various studies have dealt with the use of
electrospun scaffolds in tissue engineering of different
tissues, such as vascular tissue, neural tissue, and bone
tissue [17–21]. Most of them have indicated that MEW
is a favorable method of fabricating scaffolds for tissue
regeneration. However, only a few studies have investi-
gated the use of MEW scaffolds and membranes as a
means of enhancing oral wound healing [22, 23]. As
good cytocompatibility is a basic requirement for the ap-
plication of scaffolds and membranes in humans, this
study investigated the cell growth of typical cells of oral
soft- and hard tissues upon MEW scaffolds. PCL has
already proven its role as a valuable tissue engineering
material [24–26]. A good biodegradability as well as an
excellent biocompatibility are key features in this. Be-
sides, the relatively low melting point of approximately
63 °C makes PCL is very suitable for the MEW process
[4, 27]. Especially in bone regeneration, PCL scaffolds
yielded good results considering cell viability and cell
proliferation [21, 28]. Only medical-grade PCL was used
for the polymer melt for scaffold fabrication in this study
so that a translation to the clinical routine would basic-
ally be possible. In this manner, high-precision and
Fig. 5 Protein concentration in MG63 cells seeded on MEW box-structured PCL scaffolds of different box-sizes according to Lowry method testing
after 4 days of cell culture
Fig. 6 Cell count of MG63 cells seeded on MEW box structured PCL scaffolds of different box-sizes after 2, 3 and 4 days of cell culture
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well-defined box-shaped scaffolds were produced with-
out the use of toxic organic solvents or any other agents.
The architecture of scaffolds, size, morphology and in-
terconnectivity play an important role in the sufficient
regeneration of bone [29]. Various studies have dealt
with the issue of an optimal pore size for scaffolds in
bone-tissue engineering thus far [30–33]. The range of
pore sizes regarded as ideal here varies between 95 μm
and 500 μm; however, these values refer neither to elec-
trospun scaffolds nor to PCL as the basic material that
we examined in this study. To bridge this gap, the sizes
of the box structures were varied within the range, that
is described in current literature (225 μm, 300 μm,
375 μm, 450 μm and 500 μm scaffolds), to see if this
would lead to better cell growth of osteoblast-like MG63
cells on the medical-grade PCL scaffolds. Cell growth
was then evaluated by means of WST-1 testing, protein-
concentration measurement, and cell counting at differ-
ent time points. A slightly better cell viability was gener-
ally observed for smaller box sizes, but a definite trend,
which of the examined box-sizes between 225 μm and
500 μm promoted primary cell attachment of osteoblast-
like cells best, could not be found. Better cell viability
for smaller box sizes can be explained by the higher sur-
face area for cell adhesion. Although all scaffolds had
the same dimensions, smaller box sizes contain more fi-
bers due to the tighter arrangement of these fibers. In
general, decreased cell growth on all scaffolds compared
with the positive control groups can be partly attributed
to the experimental setup. MG63 cells display a spher-
ical morphology before seeding on scaffolds so that ini-
tial seeding on the thin fibers is hard to achieve; most of
the cells might primarily fall through the meshes. Cell
settlement might have occurred in large parts through
cells that had primarily been on the bottom of the well
and then migrated onto the scaffold.
Considering protein concentration, all examined scaf-
folds with box sizes between 225 μm and 500 μm yielded
similar results. A considerable impact of different box
sizes towards the protein status of MG63 cells was not
Fig. 7 pH values in cell culture medium of MG63 cells seeded on MEW box-structured PCL scaffolds of different box-sizes after 2, 3, and 4 days of
cell culture. Scaffold: MEW PCL scaffolds burdened with glass ring/beads, Medium: DMEM cell culture medium, MG63 + ring: MG63 cells settled
upon polystyrene cavities of multiwell plates in presence of glass ring/beads
a b
Fig. 8 Exemplary SEM micrograph of MEW PCL-scaffold. a) Overview. Box size is 225 μm and box structures are built from 2 × 5 layers of PCL fibers.
b) MG63 cells after 4 days of cell culture
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observed. A similar situation was found regarding the
cell counting of adherent cells. Although viable MG63
cells could be detected at all times during the experi-
ment on the scaffolds, different box sizes did not seem
to have a significant influence on either cell adhesion or
the growth behavior of the osteoblast-like cells.
To roughly assess the potential influence of PCL scaf-
folds on the surrounding milieu in terms of alkaline or
acidic changes, the pH values of cell culture supernatant
were observed on each day of the experiment. As a deg-
radation of the scaffolds at this early stage was not prob-
able, at no point non-physiological values were found,
Fig. 9 Phalloidin staining of MEW PCL-scaffolds after 4 days of cell culture with MG63 cells. a) Box size 225 μm, b) box size 300 μm, c) box size
375 μm, d) box size 450 μm, e) box size 500 μm
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which indicates - as expected - that within the first few
days, PCL showed no negative influence in terms of
acidic or alkaline milieu changes that may impair wound-
healing process [34].
The morphological analysis of MEW scaffolds revealed
an accurate layer-by-layer deposition of PCL fibers,
which formed the desired pre-defined geometry of inter-
connecting boxes. The accuracy of MEW in creating
Fig. 10 FDA/PI staining of MEW PCL-scaffolds after 4 days of cell culture with MG63 cells. Green staining displays living cells; red staining, dead
cells; a) Box size 225 μm, b) box size 300 μm, c) box size 375 μm, d) box size 450 μm, e) box size 500 μm
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complex porous structures has been previously de-
scribed. Filament diameters are in a low submicron
range, but sufficiently large interconnecting pores for
cell growth can be found throughout the scaffolds [6, 9].
In our study cell growth upon scaffolds was observed in
the initial stage of the cell culture mostly at fiber inter-
sections in SEM micrographs, while staining also re-
vealed cell growth alongside straight fiber parts.
Using MEW with medical-grade polymers to produce
scaffolds for improved regeneration of oral tissues pro-
vides an opportunity to generate individually planned,
high-precision, non-toxic biomaterials that can basically
be directly used in humans. Thanks to MEW’s precise
printing capabilities, the geometry of the scaffolds can
largely be chosen at will. This way, individual designs for
individual cells types/tissues can be realized. PCL scaf-
folds with pore sizes optimized for osteoblast growth
may significantly promote bone healing. Furthermore,
stratified scaffolds that contain different MEW layers
also enable enhanced wound healing for oral mucosa
and bone. By fabricating scaffolds that allow proper
osteoblast attachment, we made the first move towards
this goal. Further steps such as optimizing scaffold sur-
faces for better cell adhesion and fabricating multi-
layered MEW scaffolds tailored to different tissue types,
need to follow.
Such scaffolds/membranes would prove beneficial, espe-
cially in the field of oral and maxillofacial surgery, where
impaired wound healing in the alveolus region oftentimes
poses problems. Furthermore, a pre-implantological use of
these membranes seems suitable. In atrophic regions of
the alveolus in which elaborate bone augmentation is ne-
cessary, coverage with membranes that additionally pro-
mote bone healing should prove a promising approach to
improved GBR.
Conclusions
Using MEW, we were able to produce scaffolds out of
medical-grade polymer PCL, which enabled good cell at-
tachment for osteoblasts. SEM imaging revealed accur-
acy for the MEW process with exactly arranged fibers
with a diameter of 20 μm. Scaffolds with box geometries
of different sizes between 225 μm and 500 μm were ex-
amined. In this range, a preferred box size for initial
osteoblast attachment could not be found according to
cell viability, cell count, or protein concentration of cells.
Nevertheless, all box sizes proved to be a good substrate
for osteoblast cell growth. To further enhance osteoblast
attachment, surface modifications, such as coating the fi-
bers with calcium phosphate, seem favorable. Overall,
further laboratory testing and subsequent clinical trials
are required in order to enhance membrane properties
and transfer them into clinical routine.
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